A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy

BACKGROUND: This study aimed to establish a reliable model for predicting the overall survival (OS) of esophageal squamous cell carcinoma (ESCC) patients and identifying the potential beneficiaries of adjuvant chemotherapy after esophagectomy. METHODS: This retrospective study included 819 ESCC pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zihao, Huang, Shujie, Ben, Xiaosong, Zhuang, Weitao, Hong, Liangli, Xie, Zefeng, Zhang, Dongkun, Xie, Liang, Zhou, Haiyu, Tang, Jiming, Chen, Gang, Wu, Hansheng, Qiao, Guibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908144/
https://www.ncbi.nlm.nih.gov/pubmed/35280404
http://dx.doi.org/10.21037/atm-22-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908144/
https://www.ncbi.nlm.nih.gov/pubmed/35280404
http://dx.doi.org/10.21037/atm-22-46

Ejemplares similares